Document is current
Any future updates will be listed below
-
Authors
Català-Moll, Francesc https://orcid.org/0000-0002-2354-8648
Blázquez-Bondia, Carlos
Farré-Badia, Judit
Torres, Ferran https://orcid.org/0000-0002-7355-7913
Manzardo, Christian
Bonfill, Eva
Curran, Adrià
Domingo, Pere https://orcid.org/0000-0003-1138-5770
Podzamczer, Daniel
Force, Lluís
Falcó, Vicenç https://orcid.org/0000-0001-9626-0023
Parera, Mariona
Casadellà, Maria
Miró, José Maria https://orcid.org/0000-0001-8057-7755
Noguera-Julian, Marc
Paredes, Roger https://orcid.org/0000-0002-6553-691X
,
,
Borgognone, Alessandra
Marín, Nel
Careta, Oriol
Triviño, Valentina
,
Cruceta, Anna
Climent, Nuria
Lozano, Francisco
Plana, Montserrat
Ambrosioni, Juan
Rovira, Cristina
Hurtado, Carmen
Maleno, Maria José
Inciarte, Alexy
Castelli, Anna
Fernández, Emma
Ligero, Carmen
Serrano, Sandra
Marcos, Maria Ángeles
Rubio, Elisa
Vila, Jordi
de Lazzari, Elisa
Gatell, Jose M.
Marlano-Barletta, Daniela
,
Suanzes, Paula
Ribera, Esteve
Torrella, Ariadna
Planas, Bibiana
,
Gutierrez, Mar
Mateo, Gracia
Muñoz, Jèssica
García, Ana
Lamarca, Kanura
Millan, Lucía
Fernández, Judit
Mur, Isabel
Corbacho, Noemí
Molas, M. Ema
,
Saumoy, Maria
Acerete, Laura
Rozas, Nerea
Ferrer, Elena
Garcia, Benito
Diyacovo, Maria Silvana
Torres, Josefa
Silva, Ana
Tiraboschi, Juan Manuel
Imaz, Arkaitz
Padilla, Cristina
,
Barrufet, Pilar
Boquet, Xavier
Sempere, Gloria
-
Funding
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (84793)
- License Information
-
More Information
Article History
Received: 30 May 2025
Accepted: 11 February 2026
First Online: 4 March 2026
Competing interests
: V.F., P.D., and A.C. have received fees for educational activities and/or consultancies and/or financial support for attending conferences from Gilead Science, Janssen-Cilag, Merck Sharp & Dohme, and ViiV Healthcare. J.M.M. has received consulting honoraria and/or research grants from Angelini, Basilea, Genentech, Gilead Sciences, Janssen, Lysovant, Medtronic, MSD, Novartis, Pfizer, and ViiV Healthcare, outside the submitted work. R.P. has participated in advisory boards for Pfizer, Gilead, MSD, GSK, Atea, Lilly, Roche, AstraZeneca, ViiV Healthcare, and Theratechnologies, has participated in lectures and seminars funded by Gilead, Pfizer, GSK, and AstraZeneca, and has received research funds awarded to his institution from Gilead, Pfizer, and MSD. The remaining authors declare no competing interests.
: Where individual patient data are included, all patients provided informed consent.
